Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Funding for any future Covid-19 vaccine to be considered as part of Estimates process

By Mindo - 21st Sep 2020 | 21 views

Funding for the purchasing of any future Covid-19 vaccine stock will be considered as part of the “Estimates 2021 process”, a spokesperson for the Department of Health told this newspaper.

It has been reported that 140 vaccines are in early development and around two dozen are being tested on people in clinical trials.

Asked whether any budgeting provision is expected to be made for the purchase of any future vaccine in the coming years, the Department spokesperson told the Medical Independent that “this will be considered as part of the Estimates 2021 process”.

Department of Health, Miesian Plaza

Ireland is currently involved in a Joint Procurement Exercise (JPE) being operated by the European Commission to procure vaccines to combat Covid-19.

“Following a Government decision on 21 August, Ireland has opted into an EU Advanced Purchase Agreement (APA) with the British–Swedish drug maker AstraZeneca, which is partnering with Oxford University,” said the spokesperson.

“The EU is also in advanced negotiations with a number of other major pharmaceutical companies.… Allocation of access to vaccine doses between member states will be according to the population distribution key. The actual purchase and use of the vaccine product will remain under the responsibility of the individual member states.”

The spokesperson added that Ireland “has also indicated an expression of Interest in the World Health Organisation (WHO) linked COVAX initiative, which seeks to provide global access to Covid-19 vaccines”.

Leave a Reply

Latest
Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read